Report: AIDS drugs to top $10 billion by 2015

04/12/2007 | Reuters

Global sales of HIV/AIDS drugs could reach $10.6 billion by 2015, up from $7.1 billion in 2005, according to a report from market researcher Datamonitor. Drug companies may be pressured to cut prices in developing nations, but the West remains a lucrative and fast-growing market. Firms such as Merck, Pfizer, Gilead Sciences and Johnson & Johnson may benefit most from the market growth, the report said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA